Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita

International Journal of Surgical Pathology

Volumn 21, Issue 5, 2013, Pages 520-525

  Bohn, Olga L ^a   Whitten, Joseph ^a   Spitzer, Barbara ^a   Kobos, Rachel ^a   Prockop, Susan ^a   Boulad, Farid ^a   Arcila, Maria ^a   Wang, Lu ^a   Teruya Feldstein, Julie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

acute myeloid leukemia; aplastic anemia; dyskeratosis congenita; posttransplant lymphoproliferative disorder

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME 8; COMPUTER ASSISTED TOMOGRAPHY; DYSKERATOSIS CONGENITA; EPSTEIN BARR VIRUS; ERYTHROCYTE TRANSFUSION; FATALITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KARYOTYPE; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MONOSOMY; NEUTROPENIA; PARTIAL TRISOMY; PERITONEAL BIOPSY; PERITONEAL FLUID; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTEMIC MYCOSIS; TRISOMY; VIREMIA;

ACUTE MYELOID LEUKEMIA; APLASTIC ANEMIA; DYSKERATOSIS CONGENITA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER;

ADULT; DYSKERATOSIS CONGENITA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; LYMPHOPROLIFERATIVE DISORDERS; POSTOPERATIVE COMPLICATIONS;

EID: 84884696785     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896912468214     Document Type: Article

References (28)

1. Nelson ND, Bertuch AA. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res. 2012 ; 730: 43-51
2. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009 ; 113: 6549-6557
3. Stewart JA, Chaiken MF, Wang F, Price CM. Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat Res. 2012 ; 730: 12-19
4. de la Fuente J, Dokal I. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant. 2007 ; 11: 584-594
5. Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin North Am. 2009 ; 23: 215-231
6. Revesz T, Fletcher S, al-Gazali LI, DeBuse P. Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome?. J Med Genet. 1992 ; 29: 673-675
7. Hreidarsson S, Kristjansson K, Johannesson G, Johannsson JH. A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr Scand. 1988 ; 77: 773-775
8. Hiyama E, Hiyama K. Telomere and telomerase in stem cells. Br J Cancer. 2007 ; 96: 1020-1024
9. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet. 2008 ; 42: 301-334
10. Giraud-Panis MJ, Teixeira MT, Geli V, Gilson E. CST meets shelterin to keep telomeres in check. Mol Cell. 2010 ; 39: 665-676
11. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001 ; 413: 432-435
12. Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis. 2005 ; 34: 257-263
13. Walne AJ, Vulliamy T, Marrone A, et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet. 2007 ; 16: 1619-1629
14. Vulliamy T, Beswick R, Kirwan M, et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A. 2008 ; 105: 8073-8078
15. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet. 2008 ; 82: 501-509
16. Landgren O, Gilbert ES, Rizzo JD, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009 ; 113: 4992-5001
17. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol. 1995 ; 103: 748-755
18. Heyny-von Haussen R, Klingel K, Riegel W, Kandolf R, Mall G. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin. Am J Surg Pathol. 2006 ; 30: 900-905
19. Olagne J, Caillard S, Gaub MP, Chenard MP, Moulin B. Post-transplant lymphoproliferative disorders: determination of donor/recipient origin in a large cohort of kidney recipients. Am J Transplant. 2011 ; 11: 1260-1269
20. Swerlow SH, Webber SA, Chadburn A, Ferry JA WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4 th ed.Lyon, France: International Agency for Research on Cancer; 2008:343-349. Swerdlow SH Campo E Harris NL, ed. Lyon, France: International Agency for Research on Cancer ; 2008: 343-349.
21. Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?. Am J Surg Pathol. 2000 ; 24: 375-385
22. Kapelushnik J, Ariad S, Benharroch D, et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol. 2001 ; 113: 425-428
23. Birkeland SA, Hamilton-Dutoit S. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?. Transplantation. 2003 ; 76: 984-988
24. Craig FE, Johnson LR, Harvey SA, et al. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Diagn Mol Pathol. 2007 ; 16: 158-168
25. De Braekeleer E, Meyer C, Douet-Guilbert N, et al. Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory. Mol Oncol. 2011 ; 5: 555-563
26. Vakiani E, Nandula SV, Subramaniyam S, et al. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion. Hum Pathol. 2007 ; 38: 315-325
27. Djokic M, Le Beau MM, Swinnen LJ, et al. Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities. Genes Chromosomes Cancer. 2006 ; 45: 313-318
28. Corapcioglu F, Olgun N, Sarialioglu F, Uysal KM, Oren H, Sercan O. MLL-AF4 gene rearrangement in a child with Epstein-Barr virus-related posttransplant B-cell lymphoma. J Pediatr Hematol Oncol. 2003 ; 25: 740-742